• http://www.antidoping.ee/regulatsioonid/keelatud-ainete-nimekiri/keelatud- ainete-nimekiri-2018/ • https://www.slideserve.com/billy/ingrid-kokmann-stom-iii-tartu-2013 • https://et.wikipedia.org/wiki/Gl%C3%BCkokortikoidid_(ravimir%C3%BChm) • http://www.spordipuhtalt.ee/keelatud-ained/#glykokortikoidid • https://www.kliinik.ee/static/ravimid/SPC/SPC_1028102.pdf • https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0013905/ • https://pubchem.ncbi.nlm.nih.gov/compound/prednisone#section=Experime ntal-Properties • http://dspace.ut.ee/bitstream/handle/10062/14172/Poletikuvastased_a ined_ja_hormoonid_2009.pdf;jsessionid=C61A411CAF3C49EC00E31A56D9B96 D24?sequence=4
arvatakse olevat lümfotsüüdis tekkinud kromosoomihäiret, mis viib kontrollimatu pahaloomuliste lümfoomirakkude tekkele. Samuti arvatakse seotust mitmesuguste viirustega. (SA Tartu Ülikooli Kliinikum Hematoloogia-onkoloogia kliinik, 2012b) 7 18 Sümptomid Tavaliseimad sümptomid on nõrkud, diarröa, kaalu langus ja suurenenud lümfisõlmed. Samuti võib tuhkrul esineda köha ning raskusi hingamisel.(Williams, 2012) 19 Ravi Sagedamini kasutatakse lümfoomi leevenduseks Prednisone. Kui tuhkurt on juba ravitud sellega näiteks insulinoomi, soole- või teisi haigusi, siis ei pruugi see mõjuda. Kahjuks Prednisone ei ravi lümfoomi, see on lihtsalt leevenduseks, mis aitab parandada tuhkru elukvaliteeti. On olemas ka teisi ravimeetodeid nagu kirurgia, kiiritamine või kemoteraapia. Ükskõik, milline meetod valitakse, alustatakse sellega kiiresti, et pikendada võimalikult palju tuhkru eluiga. (Onasch, 2008) 8 KOKKUVÕTE
5) Clinical Practice Guidelines in Oncology, National Comprehensive Cancer Net- work 6) The UK Myeloma Forum, Guideline: Diagnosis and Management of Multiple Myeloma, British Journal of Haematology (2001) 115: 522-540 7) Medical Research Council’s Working Party on Leukaemia in adults. Report on the second myelomatosis trial after five years follow-up. Br J Cancer (1980) 42: 813- 822 8) Myeloma Trialist’s Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials. J Clin Oncol (1998) 16: 3832-42 9) Kyle R, Rajkumar V. Multiple Myeloma, N Engl J Med (2004) 351: 1860-73 10) Sirohi B, Powles R. Multiple myeloma. The Lancet (2004) vol 363 11) Harousseau J-L. Management of multiple myeloma. Rev Clin Exp Hematol (2002) vol 6.3 12) Rajkumar SV, Hayman S, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR et al.
put it, "a 30-year-old in a 60-year-old body." Though it was a depressing and fatalist diagnosis, it didn't appear uncommon. My closest male friends, also former competitive athletes, had all started creaking and groaning after age 30. The aches were turning into surgeries, small training injuries had become chronic pain, and we all recognized the pink elephant in the room: it was going to get worse. Much worse. For me, the straw that broke the camel's back was a series of high-dose prednisone prescriptions and epidural injections in 2009. It started with an innocuous shoulder impingement. MRIs showed no shoulder issues but uncovered cervical spine degeneration in five discs. "This is something you'll just need to live with" was the concluding remark, delivered with an inappropriate smile, from a spine surgeon who works with NHL and NFL teams. None of his recommended drugs or injections would x the problem. They were nothing more than Band-
annaabi.ee 
